Breakthrough DeepViewâ„¢ Tech at 2025 US Burn Conferences
Spectral AI used the Southern Region Burn Conference to showcase new data around its DeepView imaging and predictive analytics...
AI Drug Discovery AstraZeneca BIO-Europe Spring 2026 biopharma M&A biopharma strategy biotech funding biotech strategy business development cancer immunotherapy China Biotech CNS Pipeline Strategy competitive intelligence Disease-Modifying Therapy Drug Pricing Strategy eClinical Tech News Eli Lilly Emerging Markets FDA Approval FDA Priority Review HER2 Oncology immuno-oncology immunology licensing deals Lifecycle Management Market Access Medtronic MSS colorectal cancer Novo Nordisk Obesity/GLP-1 Obesity Drug Market Obesity Market Oncology Pipeline Patent Cliff Priority Review Voucher pulmonary hypertension Rare Disease Regeneron respiratory biologics Roche Sanofi series A funding Teva Pharmaceuticals Type 1 Diabetes Type 2 Diabetes venture capital
No videos found.
Spectral AI used the Southern Region Burn Conference to showcase new data around its DeepView imaging and predictive analytics...
Hanmi Pharmaceutical will take Aptose Biosciences private, acquiring all outstanding shares it does not already own for C$2.41 in...
As the pharmaceutical industry faces an unprecedented surge of product launches, most companies plan to handle this expansion without...
Cytomed Therapeutics has completed the acquisition of TCB-002, an allogeneic gamma delta T cell technology from TC BioPharm’s subsidiary,...
Harrow has closed its acquisition of Melt Pharmaceuticals, bringing a portfolio of non-opioid, non-intravenous sedation candidates built on Zydis...
Inotiv posted preliminary fourth-quarter fiscal 2025 revenue of $137.5–$138.5 million and full-year revenue of $512.5–$513.5 million, anchored by continued...
Kraig Biocraft Laboratories has secured a confidential pilot order to supply next‑generation recombinant spider silk yarns to a global...
Protext Mobility has signed a letter of intent with TruLeaf to pair TruLeaf’s nanotechnology with Protext’s extraction platform and...
Johnson & Johnson has agreed to acquire Halda Therapeutics for $3.05 billion in cash, adding a first-in-class proximity-based small...
NRx Pharmaceuticals has refiled its abbreviated new drug application for Ketafree, a preservative‑free intravenous ketamine, received FDA feedback indicating...
